Encapharm is a specialized HPLC column series based on fully porous, high-purity silica with advanced bonding and full endcapping technology. Designed for high-resolution reversed-phase separations, Encapharm columns offer excellent peak shape, low silanol activity, and strong hydrophobic retention, making them ideal for challenging analytical tasks in pharmaceutical, biochemical, and research environments.
Encapharm columns are optimized for consistent performance in both gradient and isocratic methods, supporting reliable separations of basic, neutral, and moderately polar analytes.
Encapharm columns combine precision bonding with reliable reversed-phase performance – ideal for demanding chromatographic applications that require robustness and reproducibility.
| Particle Sizes | 3 µm, 5 µm |
|---|---|
| Phases/Modifications | C18 |
| Pore Sizes | 130 Å |
| Surface Areas | 250 m²/g |
Fully porous, high-purity silica with advanced bonding chemistry
Full endcapping for minimized silanol interaction and improved peak shape
Strong reversed-phase retention for broad application range
Compatible with aqueous-organic mobile phases
Available in 3 µm and 5 µm particle sizes
Pharmaceutical analysis and impurity profiling
Method validation and transfer in regulated environments
Separation of basic and polar compounds
Research and development in chemical and life sciences